Related Experiment Video
Updated: May 26, 2026

Assays for Validating Histone Acetyltransferase Inhibitors
Published on: August 6, 2020
Selective roles for cAMP response element-binding protein binding protein and p300 protein as coregulators for
Irina Ianculescu1, Dai-Ying Wu, Kimberly D Siegmund
1Department of Biochemistry and Molecular Biology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California 90089-9176, USA.
Abstract:
The protein acetyltransferases p300 and cAMP response element-binding protein binding protein (CBP) are homologous, ubiquitously expressed proteins that interact with hundreds of proteins involved in transcriptional regulation and are involved globally as transcriptional coregulators. Although these two proteins acetylate and interact with overlapping sets of proteins, we found that p300 and CBP contribute to androgen-induced regulation of distinct sets of genes in C4-2B prostate cancer cells, a model of advanced prostate cancer. CBP cannot compensate for the loss of p300 to support androgen-induced expression of many genes, such as TMPRSS2 and PSA. Global gene expression analysis indicated that 47% of androgen-regulated genes are p300-dependent in these cells, whereas, surprisingly, only 0.3% of them are CBP-dependent. Chromatin immunoprecipitation analysis after depletion of cellular p300 indicated that p300 is required for androgen-induced acetylation of histones H3 and H4, methylation of histone H3 at Lys-4, and recruitment of TATA box binding protein (TBP) and RNA polymerase II, but not recruitment of the androgen receptor, on the TMPRSS2 gene in response to androgen. Thus, p300 is the dominant coregulator of the CBP/p300 pair for androgen-regulated gene expression in C4-2B cells. p300 is required at an early stage of chromatin remodeling and transcription complex assembly after binding of androgen receptor to the gene but before many critical histone modifications occur.
Insights
The protein p300, not CBP, is crucial for androgen-regulated gene expression in advanced prostate cancer cells. P300 controls key steps in gene activation, including histone modifications and transcription complex assembly.
Area of Science:
- Molecular Biology
- Epigenetics
- Cancer Research
Background:
- p300 and CBP are homologous transcriptional coregulators involved in gene regulation.
- They acetylate and interact with overlapping sets of proteins.
- Their specific roles in androgen-induced gene regulation in prostate cancer are not fully understood.
Purpose of the Study:
- To investigate the distinct roles of p300 and CBP in androgen-regulated gene expression in C4-2B prostate cancer cells.
- To determine the dependency of androgen-regulated genes on p300 and CBP.
- To elucidate the molecular mechanisms by which p300 influences androgen-induced gene expression.
Main Methods:
- Global gene expression analysis (microarray or RNA-Seq).
- Chromatin immunoprecipitation (ChIP) assays.
- Depletion of p300 using siRNA or shRNA.
Main Results:
- p300 and CBP regulate distinct gene sets in response to androgen.
- 47% of androgen-regulated genes are p300-dependent, while only 0.3% are CBP-dependent.
- p300 is essential for androgen-induced histone acetylation (H3, H4), H3 Lys-4 methylation, and recruitment of TBP and RNA polymerase II to the TMPRSS2 gene.
Conclusions:
- p300 is the dominant coregulator of the CBP/p300 pair for androgen-regulated gene expression in C4-2B cells.
- p300 acts early in the process, facilitating chromatin remodeling and transcription complex assembly after androgen receptor binding.
- CBP cannot compensate for p300 loss in supporting androgen-induced expression of key genes like TMPRSS2 and PSA.
More Related Videos
Related Concept Videos
Cell Specific Gene Expression
Master Transcription Regulators
Co-activators and Co-repressors
Negative Regulator Molecules
Abnormal Proliferation
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.

